Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif., May 04, 2022 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc., (Nasdaq: LYEL), a T-cell reprogramming company dedicated…
Generated $12.1 million in Q1 2022 EMPAVELI® (pegcetacoplan) U.S. net product revenuesReported 18-month data with intravitreal pegcetacoplan in geographic atrophy…
Achieved Oxbryta® (voxelotor) net revenues of $55.2 million in the first quarter 2022, a 41% increase year over year Strong…
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a…
– Poster highlights analysis of baseline neutralizing antibodies to AAV.7m8 and impact on ADVM-022 efficacy and safety in OPTIC –…
Results Presented Today at the Pediatric Endocrine Society’s 2022 Annual MeetingHighly significant ~75% reduction in hypoglycemia events at anticipated therapeutic…
— Data Demonstrate Rapid and Complete Wound Healing, with Six of Eight (75%) Patients Achieving Complete Healing within Four Weeks;…
New data highlights include: – Phase 3 open-label extension study data for growth hormone-deficient children treated for 2.5 years with TransConTM…
PRESS RELEASE April 30, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that the…
IRVINE, Calif., April 29, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…